| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 10 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 10 |
| 2 | TACROLIMUS OINTMENT 0.1% | 10 |
| 3 | MYCOPHENOLATE MOFETIL | 8 |
| 4 | NIVOLUMAB | 6 |
| 5 | LEVOCARNITINE | 5 |
| 6 | LEVOCARNITINE ORAL | 5 |
| 7 | PREDNISONE | 5 |
| 8 | AZITHROMYCIN DIHYDRATE | 4 |
| 9 | CYCLOPHOSPHAMIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIBACTERIAL HAND WIPES | 2 | 0.0060 |
| 1 | BENZALKONIUM CHLORIDE 0.13% | 2 | 0.0053 |
| 2 | BENZALKONIUM CHLORIDE | 2 | 0.0046 |
| 3 | LEVOCARNITINE | 5 | 0.0014 |
| 4 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 1 | 0.0009 |
| 5 | PYRIMETHAMINE | 1 | 0.0008 |
| 6 | FARICIMAB | 3 | 0.0003 |
| 7 | CALCIUM CHLORIDE INJECTION | 1 | 0.0003 |
| 8 | ENFORTUMAB VEDOTIN | 2 | 0.0003 |
| 9 | OXCARBAZEPINE | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carnitine Analog [EPC] | 5 | 0.0014 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 4 | Polyene Antifungal [EPC] | 2 | 0.0000 |
| 5 | Estrogen Receptor Antagonist [EPC] | 2 | 0.0000 |
| 6 | Erythropoiesis-stimulating Agent [EPC] | 2 | 0.0000 |
| 7 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |